Pisetsky et al reported on assay variation in the detection of antinuclear antibodies (ANA) in sera of patients with established systemic lupus erythematosus (SLE).1 The authors determined ANA in sera ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier system that delivers therapeutic antibodies directly to target antigens inside ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

A breakthrough in cancer therapy: metal-phenolic nanocarriers deliver antibodies directly to cancer cells, improving ...

AAA Biotech Launches Validated Antibodies & Research Reagents Browse AAA Biotech's new range of validated antibodies, ELISA kits, and cultu ...

A new nanozyme-antibody platform selectively targets HER2-positive tumors, disrupting gene expression and reducing metastasis ...

Researchers create nanomachines using metal and polyphenols, which enhance targeted intracellular delivery of antibodies for ...

New research reveals that nurse shark pancreases function as secondary lymphoid organs, helping produce antibodies and mount immune responses, challenging what we know about vertebrate immunity.

In a significant step towards improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

A significant percentage of patients with SSc first present with non-RP symptoms — most commonly puffy fingers/hands — and are associated with more severe disease.

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is currently being investigated as a potential therapeutic target in several ...